IMMONC
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
IMMONC
Sep 11, 2024, 05:15 |
Insight
Article of the day, September 11th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 10, 2024, 14:57 |
Insight
Article of the day, September 10th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 9, 2024, 13:18 |
Insight
Article of the day, September 9th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 8, 2024, 14:09 |
Insight
Article of the day, September 8th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 6, 2024, 12:58 |
Insight
Article of the day, September 6th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 5, 2024, 15:04 |
Insight
Article of the day, September 5th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 4, 2024, 10:54 |
Insight
Article of the day, September 4th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 3, 2024, 14:47 |
Insight
Article of the day, September 3rd, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 2, 2024, 13:49 |
Insight
Article of the day, September 2nd, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 1, 2024, 10:46 |
Insight
Article of the day, September 1st, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Aug 31, 2024, 09:52 |
Insight
Article of the day, August 31st, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Aug 30, 2024, 10:39 |
Insight
Article of the day, August 30th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Aug 29, 2024, 11:25 |
Insight
Article of the day, August 29th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Aug 8, 2024, 02:09 |
Blog
Immune Oncology Research Institute at the ASCO 2024 Annual Meeting
Immune Oncology Research Institute made the following post on LinkedIn: "IMMONC at the ASCO 2024 Annual…
Jul 13, 2024, 09:41 |
Insight
IMMONC - Immune Oncology Research Institute's Experience in Advancing Clinical Cancer Research in Armenia
Cancer affects people across the world regardless of their socioeconomic status. However, low- and middle-income…
May 30, 2024, 10:57 |
Insight
Julia Hoveyan: A year ago, the IMMONC launched the first-ever investigator-sponsored trial in pediatric oncology in Armenia
Ruzanna Papyan recently shared a post by Julia Hoveyan, Pediatric Oncologist at the Pediatric Cancer…
Apr 15, 2024, 04:04 |
Blog
Amalya Sargsyan: Proud to see IMMONC spotlighted in ASCO's latest policy statement on global equity in clinical trials
Amalya Sargsyan, Medical Oncologist at Yeolyan Hematology and Oncology Center, posted on LinkedIn: "Extremely proud to…
Feb 14, 2024, 13:40 |
Insight
Karen Bedirian: Happy to share that IMMONC received regulatory approval to conduct a trial of BAL+BOT among patients with metastatic non-small cell lung cancer
Karen Bedirian, Projects Director at Immune Oncology Research Institute, shared on LinkedIn: "Happy to share…
Feb 8, 2024, 16:56 |
Blog
IV Armenian Oncology Congress: 6 tweets from Shushan Hovsepyan
Shushan Hovsepyan, Pediatric Oncologist and Clinical Research Coordinator at the Yeolyan Hematology and Oncology Center,…
Jan 15, 2024, 08:37 |
Career
Jemma Arakelyan: I have been ranked in the top 5% of PG researchers and have received Excellent Paper Awards
Jemma Arakelyan, CEO of the Institute of Cancer and Crisis, shared on LinkedIn: "Delighted to…
Jun 13, 2023, 17:24 |
Insight
In 16 months, we have registered more cancer clinical trials in Armenia, than throughout all the years before that - Gevorg Tamamyan
Last year, on February 4th I was doing a presentation about the cancer clinical trials…
All:
21
Posts:
1 - 100
OncoDaily Announces Strategic Partnership with the Asian Fund for Cancer Research Limited (AFCR)
Peyo the Therapy Horse: Comforting Terminally Ill Patients Through Horse Therapy.
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Small Bowel Cancer: Symptoms & Causes, Types, Diagnosis and Treatment
Mikkael A. Sekeres, Candidate for Secretary of ASH
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube